Quallent Pharmaceuticals Health LLC Recall Expands for Duloxetine Delayed-Release Capsules Over Imp-
CGMP deviations: N-nitroso-duloxetine impurity above the proposed interim limit.
2,756 recalls tagged with “immediate action”.
CGMP deviations: N-nitroso-duloxetine impurity above the proposed interim limit.
Software issue that results in the display of outdated information.
Baxter Healthcare Corporation is issuing an Urgent Medical Device Recall for one lot of Continu-Flo solution sets listed below due to customer reports of tubing separation.
Convenience kits labeled as sterile have not gone through the sterilization process.
Vital sign monitoring instrument may trigger an error message during blood pressures measurements, Specifically, when the initial inflation pressure is set in the high-pressure range.
Convenience kits labeled as sterile have not gone through the sterilization process.
CGMP Deviations: Presence of a nitrosamine, N-Nitroso Carvedilol I Impurity above the current Acceptable Intake Level.




This recall involves Séfralls Hair Generation Serum. The hair serum comes in an amber dropper bottle with a white and gold dropper and a white, black and gold label. "Séfralls" and "Minoxidil" are printed on the label located on the front of the bottle.
Oyster product potentially contaminated with Norovirus
CGMP Deviations: Presence of a nitrosamine, N-Nitroso Carvedilol I Impurity above the current Acceptable Intake Level.

CGMP Deviations: Presence of a nitrosamine, N-Nitroso Carvedilol I Impurity above the current Acceptable Intake Level.

Unapproved Drug Claims and Misbranded.